# clm_BCA71643FBC3

subject: Abbott Laboratories (/record/abbott-laboratories.md)  
predicate: total_equity  
value: 37,010,000,000 United States dollar  
valid_from: 2023-03-31  
valid_to: 2023-06-30  
published: 2023-05-04  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_2FAA1610921D  
last_updated: 2026-11-08  
cite: AsOf. "Abbott Laboratories total equity: 37,010,000,000 United States dollar", as of 2023-03-31 (until 2023-06-30). Claim clm_BCA71643FBC3, https://asof.is/claim/clm_BCA71643FBC3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000162828023015699/0001628280-23-015699-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q1 FY2023, filed 2023-05-04  

## Sources

- https://www.sec.gov/Archives/edgar/data/1800/000162828023015699/0001628280-23-015699-index.htm (primary, SEC EDGAR 10-Q Q1 FY2023, published 2023-05-04)

## Supersedes

- [Abbott Laboratories](/record/abbott-laboratories.md) | total_equity | 36,686,000,000 United States dollar | valid 2022-12-31 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_BCA71643FBC3](/claim/clm_BCA71643FBC3.md) | [clm_B43602CFF805](/claim/clm_B43602CFF805.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.